Introduction
In recent times, the detection of fetal nucleated cells in the maternal peripheral circulation and the endocervical canal has dominated the field of research aimed at devising non-or minimally invasive prenatal diagnostic tests (Adinolfi, 1992 (Adinolfi, , 1997 Zheng et al., 1995) . The presence of trophoblastic cellular elements in maternal peripheral blood and transcervical samples raises interesting questions, because, as well as the possibility of using these cells for non-invasive prenatal diagnoses, the shedding of placental cellular elements may have important physiological implications.
Since 1893, human trophoblasts have been shown to migrate from the placenta into the uterine veins reaching the lung, where they form emboli (Schmorl, 1893; Thomas et al., 1959; Attwood and Park, 1961; Iklé, 1964; Jaameri et al., 1965) . In 1971, Shettles suggested that, during pregnancy, a similar shedding occurs into the uterine cavity, and that chorionic cellular elements from the degenerating villi could reach the endocervical canal. Using cotton swabs, he retrieved transcervical cell (TCC) samples and tested them with a Y-chromosome fluorescent dye (quinacrine mustard) for the presence of trophoblasts derived from male fetuses. At the time of publishing his brief note, he had correctly diagnosed the sex of 10 fetuses. However, subsequent investigations produced contradictory results, mainly because samples were collected also at late stages of gestation and inadequate methods were employed for the retrieval (cotton swab) and analysis of the samples (for references see Adinolfi, 1997) .
A different approach was introduced by Rhine et al. (1975 Rhine et al. ( , 1977 Rhine et al. ( , 1979 , based on the hypothesis that trophoblastic cellular elements would accumulate behind the cervical mucus plug. Using an 'antenatal cell extractor', they flushed the endocervical canal with a sterile saline 1 To whom correspondence should be addressed solution, part of which was immediately collected. The TCC samples were then cultured in vitro and the presence of fetal cells established by staining metaphase spreads; the banding patterns of the trophoblastic cells were expected to differ from those present in the maternal chromosomes.
In one study, fetal cells could be detected in 16 out of 36 TCC samples tested (Rhine et al., 1977) . In another investigation, some TCC metaphases were found to contain the Y chromosome when the mother had a male fetus (Rhine and Milunsky, 1979) . Unfortunately, Goldberg et al. (1980) repeated these investigations, but failed to observe metaphases of fetal origin in their in-vitro cultures despite having noticed trophoblastic clumps in the original samples.
The difficulty of visualizing how trophoblastic cells could reach the uterine cavity (during the early stages of gestation) might have overshadowed early studies, since the decidua capsularis is thought to have a continuous, intact surface, not readily permeable to the underlying trophoblastic cells (Figure 1 ). This problem has not yet been solved, but a current working hypothesis is that small areas of erosions allow the invasive trophoblastic cells to cross the decidua capsularis and reach the uterine cavity until 13-15 weeks of gestation, when this space disappears. However, this hypothesis does not explain the presence of syncytiotrophoblastic cellular elements in TCC samples .
The discovery that, at a relatively early stage of gestation, enough fetal cells can be collected by chorion villus sampling (CVS) for prenatal diagnostic tests, also contributed to reduce interest in the detection of trophoblastic cells in endocervical samples. The introduction of new molecular techniques, such as the polymerase chain reaction (PCR) and fluorescence in-situ hybridization (FISH), acted as new incentives to explore further the possibilities of using TCCs for non-or minimally invasive tests. Griffith-Jones et al. (1992) , employed a PCR assay to analyse TCCs collected by cotton swabs or lavage and were able to detect chromosome Y-derived sequences in samples retrieved from mothers with male fetuses. However, once again doubts were expressed about these results by Morris and Williamson (1992) who were not able to replicate the study and had observed a high frequency of false positive or negative results. Since PCR assays may amplify DNA sequences from contaminating cells derived from the seminal fluid of male partners, in a subsequent study FISH tests were used to evaluate the frequency of cells with Y chromosome signals in TCC samples retrieved from mothers with male fetuses (Adinolfi et al., 1993) . FISH assays have the added advantages of allowing enumeration of the incidence of fetal cells in each TCC sample. When double colour FISH with X and Y probes is used, contamination by spermatozoa that have only one X and one Y, is excluded.
In the first study, when FISH tests were used, one case of trisomy 18 was detected and Y-derived signals could be seen in TCC samples retrieved from mothers with male fetuses (Adinolfi et al., 1993) . These preliminary findings prompted us and other investigators to pursue further systematic research aimed at devising efficient methods for the collection and analysis of the TCC samples, with the ultimate aim of assessing the possibility of performing prenatal diagnoses by a minimally invasive procedure.
Collection of TCC samples
TCC samples have been collected by cotton swabs, cytobrush, aspiration of the cervical mucus with a catheter (3 mm in diameter) attached to a syringe filled with 3-5 ml of saline, aspiration with a tube for endometrial biopsy (Pipelle De Cornier), lavage of the endocervical canal with 5 ml of sterile saline and uterine lavage with up to 20 ml of saline (for references see Rodeck et al., 1995; Adinolfi, 1997) . The great majority of the samples has been obtained before termination of pregnancy (Tables I and II) ; in only a few investigations, TCCs have been collected during ongoing pregnancies, prior to an invasive prenatal diagnostic procedure (Adinolfi et al., 1995a,c; Massari et al., 1996) .
Soon after being collected, TCCs should be examined under an inverted microscope and the degree of cellularity recorded (Figure 2 ). Most samples contain a variety of maternally derived cells including squamous and endometrial cellular elements. The incidence of these different types of cells is variable and depends on the method used for the collection of the TCC sample. Each TCC sample is usually separated into small aliquots which are then used for the various types of tests (Figure 2 ). For example, for FISH and PCR assays, an aliquot of the sample should be incubated with acetyl cysteine in order to dissolve the mucus and obtain a suspension of single cells. For immunohistochemical staining, a small aliquot of TCCs can be suspended in culture media containing 10% fetal calf serum (FCS); the addition of FCS or rabbit serum has been shown to improve cellular morphology in smear preparations . In some studies, aliquots of TCC samples have been used for short-term in-vitro cultures (Ishai et al., 1995; Maggi et al., 1996) . Using an inverted microscope, it is possible to collect clumps of cells with the morphological characteristics of trophoblastic cellular elements. Such clumps, after being carefully washed, can be used for FISH or PCR tests (Figure 3 ) Sherlock et al., 1997) . At present, the isolation of such clumps provides the only method for the prenatal detection of X-linked or recessive inherited disorders (Adinolfi et al., 1997) .
Analysis of TCC samples
The range and morphology of the cells present in TCC samples can be assessed by conventional staining. Aspirate and lavage samples may contain clumps of cells with the characteristics of trophoblastic cells ( Figure 4) ; their incidence being 30-50%. Briggs et al., 1995) . Maternal leukocytes, macrophages, squamous and endocervical cells are present in the great majority of samples . Cellular debris is more frequently seen in samples collected with a cytobrush .
Immunohistochemical staining of TCCs has been performed with monoclonal antibodies (MAbs) raised against placental cells, macrophages and epithelial membrane antigens (Griffith-Jones et al., 1992; Adinolfi et al., 1993; Bulmer et al., 1995) . MAbs FT1.41.1, NDOG1 and 340 react with syncytial fragments; MAbs BC1 and NDOG5 (both preferentially reactive with extravillous trophoblast populations) show surprisingly little reactivity with cytotrophoblastic cells present in TCC samples ; however, MAb 340 reacts even with single cells. MAbs against macrophages and epithelial cell antigens have been useful to assess the incidence of these types of cells in TCC samples .
In most studies PCR and FISH assays have been used to detect Y-derived sequences present in trophoblastic cells shed into the endocervical canal from male fetuses. These approaches have the disadvantage that the detection of fetal cells is limited to about half of all retrieved TCC samples. Tables I and II show that the frequency with which cells with chromosome Y sequences have been observed in samples collected by cotton swabs, cytobrush, aspiration or lavage is variable, and depends on the skill of the operator . When FISH is used, even if several hundred nuclei are analysed, some samples may appear to be free of fetal cells. However, the presence of trophoblastic cells can be detected by the amplification of chromosome Y-derived DNA sequences, using more sensitive PCR assays.
An analysis of the results published so far, based on the detection of cells with Y-derived sequences by PCR or FISH, allows the following conclusions to be drawn: few samples collected by swabs contain fetal cells, due to the limited number of trophoblasts and the high level of contaminating maternal squamous cells. The cytobrush method has the disadvantage of increasing the frequency of maternal cells and cellular debris. The incidence of fetal cells in each sample is lower than that observed in lavage samples .
Aspiration of the endocervical mucus with a single cannula results in the detection of fetal cells in 50-70% of TCC samples from mothers with male fetuses (Tables I and  II) . In a study aimed at assessing whether trophoblastic cells were more frequent in the mucus present at the cervical or the uterine pole of the endocervical canal, samples were collected by aspiration followed by lavage (Adinolfi et al., 1995c) . Eight out of 13 aspirate samples and eight out of 13 lavage samples had cells containing Y-derived sequences when the mothers had male fetuses (Table III) . However, the correct diagnosis of the sex of male fetuses was reached in 12 out of all 13 cases tested, when the total results were combined. No false chromosome Y positive results were observed in TCC samples obtained from mothers with female fetuses.
In a recent studies, when the endocervical mucus was collected by a simple aspiration technique, using Pipelle catheters, PCR analysis documented the presence of fetal cells in 80% of samples obtained from mothers with male fetuses (Table IV) . In most investigations reported in Tables I and II no false Y-positive cases were observed using either PCR or dual colour FISH assays with X and Y probes, when the TCC samples were collected from mothers with female fetuses. However, Overton et al. (1996) observed a high incidence of false positive and negative PCR and FISH results. The detection of Y-derived DNA sequences in a high percentage of TCC samples was probably due to contamination during the PCR assays. Unfortunately no data are presented from control female donors. Contradictory results were also obtained using different types of PCR tests; for example, when the TCC samples were retrieved from mothers with male fetuses, the more sensitive PCR tests were detecting Y sequences with a lower frequency than the less sensitive PCR tests.
The presence of fetal cells has been confirmed by detecting in TCC samples chromosome specific markers inherited by the fetus from the father but absent in the mother. Since these small tandem repeats (STRs) are highly polymorphic, most individuals and therefore parents as well, are heterozygous (Pertl et al., 1994 (Pertl et al., , 1996 . Thus, as shown in Figure 5 , when DNA extracted from maternal, placental and TCC samples is tested by quantitative fluorescent PCR (QF-PCR), in several cases it is possible to observe that, of the two STR markers present in placental tissue, one is present in the maternal DNA, while the other is unique and must have been inherited from the father of the fetus. The corresponding TCC samples may have three STR products, one of which is present in the placenta as well. The detection of these paternally inherited STR markers documents the presence of fetal cells in TCC samples Adinolfi et al., 1995b ). Due to the high incidence of maternal cells in TCC samples and the low sensitivity of the test, fetal STR markers (inherited from the father) can only be seen if trophoblastic cells are present in concentrations of >2.5% . As shown in Table IV , STR markers of fetal origin have been observed in about half of the TCC samples collected by Pipelle.
In-vitro cultures of transcervical cells
Five groups of investigators have used in-vitro cultures in order to identify the origin and frequency of trophoblastic cellular elements in TCC samples (Rhine et al., 1975; 1977; Rhine and Milunsky 1979; Goldberg et al., 1980; Bahado-Singh et al., 1995; Ishai et al., 1995; Maggi et al., 1996) .
By flushing the endocervical mucus with physiological saline, Rhine et al. (1977) cultured TCCs and, as already mentioned, observed that 16 out of 36 cultures contained metaphase spreads with banding patterns different from those seen on chromosomes prepared from maternal lymphocytes. In another investigation (Rhine and Milunsky, 1979) , the presence of fetal cells was confirmed by the detection of the Y chromosome in some metaphase spreads.
Unfortunately, Goldberg et al. (1980) repeated these experiments, but failed to grow fetal cells, despite having observed cytotrophoblastic cellular elements in the original samples. The reason for these discrepant results is probably due to the length of their in-vitro cultures; if TCCs are cultured for a prolonged period of time, maternal fibroblasts outgrow trophoblastic cells.
Out of 28 short-term TCC cultures tested by Ishai et al. (1995) , 19 contained metaphase spreads that could be karyotyped and shown to be of fetal origin. Maternal contamination at a level near 10% proved to be less of a problem than anticipated. In six TCC samples, metaphases could be seen by direct preparation and karyotyped within 24 h from the time of collection. Maggi et al. (1996) , attempted 60 short-term TCC in-vitro cultures; metaphase chromosomes could be seen in 40 cultures; of these, 39 had exclusively male or female cells. The results of sexing the fetuses on TCC cultures were in agreement with those obtained using placental tissues.
Detection of chromosomal disorders
In the course of many investigations aimed at detecting trophoblastic cells in TCC samples, several cases of fetal aneuploidies have been observed (Table V) . Most of these studies were performed on TCC samples retrieved from women not at risk of having fetuses with chromosome abnormalities.
A case of trisomy 18 was seen among the first small group of TCC samples retrieved by lavage and tested by FISH (Adinolfi et al., 1993) . Trisomies 21, 16, 15, 13, mosaic trisomy 12, triploidy and sex chromosomes aneuploidies have been observed by Massari et al. (1996) , Maggi et al. (1996) , and Sherlock et al. (1997) . A case of chromosome abnormality in a mother was diagnosed only after testing TCC samples. At 11 weeks gestation, a twin pregnancy with two distinct placentae was observed by ultrasound tests carried out prior to termination of pregnancy. TCC cells, placental and fetal tissues were collected together with a maternal blood sample. Interphase FISH analysis of the TCC lavage revealed the presence of two populations of cells: the first with two X and a Y chromosome signals and the second with one X and two chromosome Y signals. In view of the apparent absence of maternal cells with two X chromosomes, maternal peripheral blood lymphocytes were tested by FISH and found to contain two X and one Y fluorescent signals. Conventional cytogenetic analysis documented that the mother had a 15p/Yq translocation 46,XX,t(Y;15); by testing placental tissues, the two fetuses where found to be chimeric. One twin had a predominant cell population with two chromosome X and one Y fluorescent signals due to the 15q/Yq translocation, while the other had one X and two Y signals. Thus the fetus was male with normal X and Y chromosomes and the translocated Yq .
When clumps of cells were isolated from two other TCC samples (from a fetus with triploidy and another with a chromosome complement 47XXY), FISH analysis documented the exclusive presence of fetal cells in several clumps . This finding suggests that TCC samples can be used for prenatal diagnosis of major chromosome abnormalities and that minor chromosomal disorders can be detected once direct or short term in-vitro cultures can be successfully employed.
Prenatal detection of fetal rhesus (Rh)D DNA sequences
In a pilot study, TCC cells were retrieved by lavage from six women at 6-13 weeks gestation, prior to termination of pregnancy, and from six mothers by aspiration before CVS. All mothers were serologically Rh(D)-negative. Two sets of primers specific for the three prime untranslated RhD region in exon 4 of Rh(Ce) were employed in a duplex PCR assay to analyse the samples together with maternal peripheral blood and chorionic or other fetal tissues. In four cases the Rh phenotype was investigated serologically on chord blood samples collected at the time of delivery. In the majority of the cases the PCR results on TCCs were in agreement with those obtained by testing fetal tissues. However, in two cases, the TCC samples retrieved by aspiration or lavage appeared to be Rh(D) negative while the neonate and the fetus were negative (Adinolfi et al., 1995a) . Further technical improvements are required before the PCR tests can be used for the prenatal diagnosis of Rh incompatibility.
Prenatal detection of haemoglobin (Hb) mutations using TCCs
While whole TCC samples can be tested for fetal sex, major chromosome disorders or Rh(D) blood groups, only single cells or isolated clumps of trophoblastic cellular elements, free of maternal contaminants, can be used for the prenatal diagnosis of X-linked or autosomal recessive diseases.
The first successful attempt at performing prenatal tests of Hb disorders had been achieved by using clumps of trophoblastic cells isolated from TCC samples retrieved from couples known to be carriers of Hb mutations (Adinolfi et al., 1997) . Six pairs of parents, known to be carriers of thalassaemia or Hb mutations were selected and TCC samples collected at 10-12 weeks' gestation by aspiration of cervical mucus prior to CVS. The Hb mutations affecting each subject are shown in Table VI . Aliquots of the samples were suspended in phospho-buffered saline and clumps of cells with the apparent morphology of trophoblastic cells were collected and repeatedly washed to remove contaminating maternal cells. DNA was extracted from each individual clump and from appropriate samples.
As the Hb mutations present in the carrier parents were known, all TCC-derived clumps of cells were tested without knowledge of the results of the prenatal diagnostic analysis performed on CVS tissues using the amplification refractory mutation system (ARMs). Details of the methods employed for the detection of the mutations are described in Adinolfi et al. (1997) .
As shown in Table VI, in the first case two out of three clumps contained only cells with normal Hb alleles; therefore it was possible to conclude that the fetus was not affected. This result was in agreement with the prenatal test independently carried out on CVS. In case 2, only clumps with the maternal mutation were observed. Since the fetus was normal (as shown by the CVS test) the clumps were either of maternal origin or contained a mixture of fetal and maternal cells. Three clumps from case 3 showed a pattern of compound heterozygosity; however the fetus had not inherited the HbS mutation so all clumps must have been contaminated with maternal cells. Three clumps from case 4 showed heterozygosity for the paternal mutation, in agreement with the results of testing the relative CVS samples. The diagnosis reached in cases 5 and 6 were also in agreement with the results of the CVS test, but the possibility of contamination of the clumps with maternal cells cannot be excluded. These preliminary findings suggest that the prenatal diagnosis can be performed using isolated clumps of cells, but the problem of maternal contamination must still be solved. This problem can be avoided if parental DNA polymorphic markers linked to the gene of interest are used to assess the presence of maternal cells in the clumps. Alternatively the tests could be carried out using single cells isolated by micromanipulation or clones of TCC cells obtained from in-vitro cultures.
Discussion
After more than 36 years of investigations, the central question is not whether trophoblastic cells are present in the endocervical canal, but if the methods employed for their collection and detection allow them to be used for prenatal diagnostic tests. It has been repeatedly shown that at early stages of human pregnancy, trophoblastic cells are shed into the uterine vein, ultimately forming emboli in the maternal lung. However, these cells can be detected in the peripheral circulation of only a few pregnant women and with an incidence too low to warrant their possible use for prenatal diagnosis (Adinolfi, 1992 (Adinolfi, , 1995c Johansen et al., 1995) . The shedding of trophoblastic cells into the uterine cavity until 13-15 weeks of gestation, is probably a physiological phenomenon which takes place in all normal human pregnancies. The detection of clumps of syncytio-and cytotrophoblastic cells in samples retrieved by aspiration of endocervical mucus cannot be due to a mini-CVS or placental biopsy, as suggested (Fisk 1995; Overton et al., 1996) , since villi are covered by the decidua capsularis. With this method of collection, the point of the catheter does not reach the placental tissues . a Mutations causing β-thalassaemia in introns 1= 5, 6, 110 and exon 1 = C30. In mother 3, the HbS mutation was in exon 1. Four bp deletion in mother 6 (del 1); 619 bp deletion in father 6 (see text). In cases 1 and 4 the correct diagnosis of thalassaemia on some clumps (case 1 = normal fetus; case 2 = fetus carrying the paternal mutation) was performed. In cases 5 and 6, although the correct diagnosis was performed, the possibility of maternal cell contamination of the TCC samples could not be excluded.
The two factors that seem to play a major role in affecting the incidence with which fetal cells can be detected in TCC samples retrieved between 6-7 to 13-15 weeks gestation are the methods employed for the collection and the molecular techniques used for the detection of fetal cells. Collection by cotton swabs has been repeatedly shown to be unreliable (Adinolfi et al., 1995c) . It is not surprising that, in some studies, this method has produced false positive or negative results (Morris and Williamson, 1992; Overton et al., 1996) , since it also increases the chances of collecting cells from male partners.
The incidence of fetal cells in samples collected by aspiration or lavage is affected by the operator and by the separation of each specimen into small aliquots which are then tested by FISH or PCR assays. In most investigations, analysis by FISH has been limited to only a few hundred nuclei. In these conditions, low incidences of fetal cells (<0.5%) can be missed. Involuntary or intentional selections, due to the inclusion or not of clumps of cells into each aliquot, may greatly affect the percentage of fetal cells detected in a single sample. For example, in our early studies, cell clumps were deliberately removed from aliquots of TCC samples in order to prepare single nuclei for FISH analysis, thus reducing the incidence of fetal cells.
The introduction of automatic scanning methods for the detection of FISH signals should greatly increase the number of cells that can be analysed in each sample. Equally advantageous should be the use of immunohistochemical staining with McAbs raised against placental antigens, followed by FISH tests. This approach or, for example, the detection by reverse transcriptase PCR (RT-PCR) of human chorionic gonadotrophin (HCG) mRNA followed by FISH should allow the identification of cells derived from female fetuses.
PCR assays have been employed successfully for the detection of chromosome Y-derived or Rh(D) DNA sequences; however this approach has limited diagnostic applications when testing whole TCC samples for X-linked or recessive diseases. For the prenatal diagnosis of these disorders it is essential to isolate trophoblastic cells using either MAbs, density gradients or short-term in-vitro cultures. In-vitro cultures have already been successfully used in some studies (Rhine et al., 1975 (Rhine et al., , 1977 Rhine and Milunsky 1979; Ishai et al., 1995; Maggi et al., 1996) and their efficiency may be improved by the appropriate selection of culture media.
One of the advantages of using TCCs for prenatal diagnoses is that endocervical samples can be collected at early stages of gestation, and that a second sample can be collected after an interval of only 1 week, if the first specimen does not contain fetal cells (Ishai et al., 1995) .
An important question that must be answered is whether the collection of TCC samples by aspiration or endocervical lavage is associated with maternal or fetal risks. So far, only a preliminary study has been carried out, when TCC samples were collected by aspiration during pregnancy, prior to CVS (Adinolfi et al., 1995c; . Although preliminary, these results suggest that this procedure does not increase the risks of infection or abortion. However, further trials are needed to reach any definitive conclusion about the risks of this minimally invasive procedure, and as to whether fetal cells can be retrieved from ongoing pregnancies with a frequency similar to that observed when TCC samples are obtained before termination of pregnancy.
In view of the constant improvements of FISH and other molecular techniques for the detection of normal and abnormal DNA sequences in single cells, perhaps it is possible to conclude by expressing a moderate optimism about the possibility of using TCCs for the prenatal diagnosis of selected inherited disorders.
